FORMA GALENICA DE ADMINISTRACION ORAL PARA ANIMALES, SU PROCEDIMIENTO DE PREPARACION Y SUS APLICACIONES

• Main Authors: DERRIEU, GUY, SCHUMACHER, CAROLIN L, AUBERT, ANDRE, RAYNIER, BERNARD
• Format: Patent
• Language: Spanish
• Published: 01.03.1997
• Edition: 6
• Subjects: FODDER; FOODS OR FOODSTUFFS; HUMAN NECESSITIES; HYGIENE; MANUFACTURE OR TREATMENT THEREOF; MEDICAL OR VETERINARY SCIENCE; NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS,MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES ASDISCRETE UNITS; NANOTECHNOLOGY; PERFORMING OPERATIONS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES; TRANSPORTING

FORMA GALENICA PARA LA ADMINISTRACION ORAL DE SUSTANCIAS QUIMICAS O MEDICAMENTOSAS, TALES COMO VITAMINAS, OLIGOELEMENTOS, AMINOACIDOS, SUSTANCIAS NUTRICIONALES, VACUNAS, ETC..., A ANIMALES DOMESTICOS O SALVAJES Y SU PROCEDIMIENTO DE OBTENCION. DICHA FORMA GALENICA COMPRENDE: UN NUCLEO CENTRAL HIDROSOLUBLE Y POROSO, QUE COMPRENDE: LIGANTES SELECCIONADOS ENTRE POLIPEPTIDOS, POLISACARIDOS, POLIMEROS Y COLOIDES, Y/O DILUYENTES SELECCIONADOS ENTRE POLIOLES, OXIDOS METALICOS, CARBONATOS, FOSFATOS O CELULOSA MICROCRISTALINA, Y UN CANTIDAD EFICAZ DE AL MENOS UNA SUSTANCIA BIOACTIVA Y UNA CAPA EXTERNA, CON CARACTER HIDROFOBO Y APETENTE, QUE COMPRENDE: AL MENOS UNA SUSTANCIA LIPIDICA ELEGIDA ENTRE LOS ALCOHOLES GRASOS, LOS ESTERES DE GLICEROL, LOS ACEITES HIDROGENADOS, LAS CERAS, LA PARAFINA, LA LANOLINA, EL ACEITE DE COPRA Y LAS SALES DE ACIDOS GRASOS; UN AGENTE DE MODULACION DE LA DESINTEGRACION Y DE LA ADHESION DE DICHA CAPA EXTERNA, ELEGIDA ENTRE POLIMEROS, Y SUSTANCIAS APETENTES, NATURALES O SINTETICAS. PCT No. PCT/FR94/01251 Sec. 371 Date Aug. 1, 1996 Sec. 102(e) Date Aug. 1, 1996 PCT Filed Oct. 27, 1994 PCT Pub. No. WO95/11665 PCT Pub. Date May 4, 1995A dosage form for orally administering chemical or medicinal substances such as vitamins, trace elements, amino acids, nutritive substances, vaccines, etc., to domestic or wild animals, and a method for preparing same, are disclosed. Said dosage form includes: a porous water-soluble central core containing binders selected from polypeptides, polysaccharides, polymers and colloids, and/or diluents selected from polyols, metal oxides, carbonates, phosphates and microcrystalline cellulose, and an effective amount of at least one bioactive substance; and a palatable hydrophobic outer layer containing at least one lipid substance selected from fatty alcohols, fatty acids, glycerol esters, hydrogenated oils, waxes, paraffin, lanolin, coconut oil and fatty acid salts; a polymeric agent for modulating the disintegration and adhesion of said outer layer, and natural or synthetic palatable substances.